Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced that Daniel M. Bradbury has been promoted to President and Chief Operating Officer. Bradbury ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE